Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.
Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, Dutkowski R, Hoffmann G, Breidenbach A, Lindemann L, Carey E, Boak L, Gieschke R, Sacks S, Solsky J, Small I, Reddy D.
Toovey S, et al.
Drug Saf. 2008;31(12):1097-114. doi: 10.2165/0002018-200831120-00006.
Drug Saf. 2008.
PMID: 19026027
Review.